Recent progresss in immunological investigation are altering our knowledge of the body's immunity. A key domain focuses on harnessing the power of engineered T cells, particularly CAR-T treatment, to target and eliminate cancer cells with remarkable specificity. Simultaneously, investigations into the gut microbiome are demonstrating its profound i